P. J. Welch

发表

TFSOI-can it meet the challenge of single chip portable wireless systems?

D. J. Monk, W. M. Huang, D. C. Diaz, 1997, 1997 IEEE International SOI Conference Proceedings.

Involvement of Proteasome α-Subunit PSMA7 in Hepatitis C Virus Internal Ribosome Entry Site-Mediated Translation

P. J. Welch, M. Manns, F. Wong-Staal, 2001, Molecular and Cellular Biology.

Expression of ribozymes in gene transfer systems to modulate target RNA levels.

P. J. Welch, F. Wong-Staal, J. Barber, 1998, Current opinion in biotechnology.

State-of-the-art modified RNAi compounds for therapeutics.

P. J. Welch, E. Carstea, Shelley R. Hough, 2005, IDrugs : the investigational drugs journal.

A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle

P. J. Welch, Jean Y. J. Wang, 1993, Cell.

Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms

P. J. Welch, J. Wang, Jean Y. J. Wang, 1995, Molecular and cellular biology.

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.

P. J. Welch, M. King, P. Welcsh, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Expression of tandem glutathione S-transferase recombinant genes in COS cells for analysis of efficiency of protein expression and associated drug resistance.

P. J. Welch, R. Puchalski, W. E. Fahl, 1991, Molecular pharmacology.

Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle.

P. J. Welch, J. Wang, Jean Y. J. Wang, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Coordinated synthesis and degradation of cdc 2 in the mammalian cell cycle ( cell synchronization / phosphotyrosine / p 34 ad 2 / cdc 2 transcription / primary human fibroblasts )

P. J. Welch, Jean Y. J. Wang, 2022 .

Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.

P. J. Welch, F. Wong-Staal, Q. Li, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Differentiation of Mouse Embryonic Stem Cells after RNA Interference‐Mediated Silencing of OCT4 and Nanog

P. J. Welch, Shelley R. Hough, Ian Clements, 2006, Stem cells.

RNAi specificity: how big of an issue is it?

P. J. Welch, D. Samarsky, 2005, Pharmacogenomics.

A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation

Qi-Xiang Li, Joan M. Robbins, Peter J. Welch, 2000, Nucleic Acids Res..

Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.

P. J. Welch, J. Wang, J Y Wang, 1995, Genes & development.

The retinoblastoma tumor suppressor protein.

P. J. Welch, J. Wang, E. Knudsen, 1994, Advances in cancer research.

RNAi in Drug Development

P. J. Welch, E. Carstea, A. N. Harris, 2013 .

Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes.

P. J. Welch, C. Zhou, F. Wong-Staal, 2000, Genomics.

C-SPACE (cleavage-specific amplification of cDNA ends): a novel method of ribozyme-mediated gene identification.

P. J. Welch, F. Wong-Staal, C. Beger, 2001, Nucleic acids research.

Inhibition of HIV Replication by the Hairpin Ribozyme

P. J. Welch, F. Wong-Staal, A. Hampel, 1996 .

A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection.

P. J. Welch, Mang Yu, S. Yei, 1996, Gene therapy.